Request Deal Involvement
Arcadia Investment Partners-backed Cristae Therapeutics completed the acquisition of a novel bile-acid therapeutics business from Advent International for $25m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
CMS Legal
or
Principals
bidder
CRISTAE THERAPEUTICS
target
ADVENT INTERNATIONAL (NOVEL BILE-ACID THERAPEUTICS BUSINESS)
vendor
ADVENT INTERNATIONAL CORPORATION
bidder
ARCADIA INVESTMENT PARTNERS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite